Hay Buus
- "oncerns, and thus promote ethical research.
To evaluate whether IL-6 inhibitor tocilizumab (TCZ) reduces mortality among hospitalized COVID-19 patients.
Systematic review and meta-analysis of randomized […]"
View
Active 1 year, 5 months ago